Clinically Tested Recombinant Human Serpina3/aact Protein (his Tag) With A 80% Price Cut [1hl9PeHY]

Clinically Tested Recombinant Human Serpina3/aact Protein (his Tag) With A 80% Price Cut [1hl9PeHY]

Discover the power of recombinant human SerpinA3/AACT protein, a high-quality, His-tagged recombinant protein derived from HEK293 cells. This advanced protein is designed for various applications in research and diagnostics, offering a reliable source of this important serine protease inhibitor.

Product Features and Specifications

Our recombinant SerpinA3/AACT protein is produced using state-of-the-art biotechnology, ensuring high purity and consistent quality. Key features include:

• Purity: > 90% as determined by reducing SDS-PAGE.
• Endotoxin Level: < 1.0 EU per μg of the protein, as determined by the LAL method.
• Expression Host: HEK293 Cells
• Sequence: His24-Ala423(Lys267Arg)
• Accession Number: P01011

With a calculated molecular weight of 46.3 kDa and an observed molecular weight of 50-80 kDa, this protein is ideal for a wide range of research applications.

Applications and Benefits

The recombinant human SerpinA3/AACT protein is a valuable tool for studying the role of serine protease inhibitors in various biological processes. This protein has been shown to inhibit neutrophil cathepsin G and mast cell chymase, making it useful for research on inflammation, liver disease, and neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. By offering a reliable source of SerpinA3/AACT, our product enables researchers to advance their studies and contribute to the understanding and treatment of these complex conditions.